PTBP1 and Parkinson disease: Similarly, researchers have found that injection of AAV-GFAP-CasRx-Ptbp1 into the striatum of a PD mouse model using the newly developed, highly specific, and efficient RNA-targeting CRISPR system CasRx resulted in a 10% reduction in the expression of the RNA-targeted PTBP1 gene.